Additionally, increased levels of immunophenoscore, such as IPS–CTLA4 blocker score and IPS–PD1/PDL1/PDL2 blocker score, indirectly suggested the higher tumor immunogenicity for subjects in the low-risk score group. The gene discussed is PDCD1LG2; the disease is neoplasm.